A CGCI-II EP Suite is installed in the Na Homolce Hospital in Prague, Czech Republic. Under the direction of Dr. Petr Neuzil, Head of Cardiology for the Hospital, and Dr. Vivek Reddy, Professor of Medicine and Director of Cardiac Arrhythmia Service at Mount Sinai School of Medicine, in New York City, the Prague installation was established to take part in a multi-site randomized study of paroxysmal atrial ablation procedures with 100 patients using protocols and standards that would match or exceed EU and FDA requirements. Results from the trail not only provide further commercial validation amongst the CGCI approved countries, but also help provide base data that create the path U.S. FDA (501K) Certification.